Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPHRM.L Regulatory News (PHRM)

  • There is currently no data for PHRM

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Announcement of Appointments

11 Mar 2009 09:49

RNS Number : 6731O
Phorm Inc
11 March 2009
 



Phorm, Inc. ("Phorm" or the "Company")

Announcement of Appointments 

 

Phorm (AIM: PHRM and PHRX), the online advertising technology company, is pleased to announce the appointments of Sarah Simon as Financial and Strategic Development Officer and Mike Moore as Global Commercial Director. 

Sarah will have responsibility for the management of investor, analyst and shareholder relationships and financial communications. She will also provide analysis, research and strategic guidance to the business on all financial issues. Sarah reports to Phorm's CEO, Kent Ertugrul.

Sarah joins from Morgan Stanley where she spent 15 years and was a Managing Director in European Equity Research. She started her career in corporate finance, working on mergers and acquisitions, IPOs and restructuring then moved to equity research where she spent 12 years specialising in coverage of the European Media and Internet market. 

Mike will join Phorm on April and will be responsible for managing the fast-growing commercial opportunities for Phorm's technology as it is deployed globally. This will include overseeing partnership arrangements with advertisers and publishers to ensure the optimal performance of ad campaigns served through the Open Internet Exchange (OIX) Mike will report to Phorm's deputy CEO, Nan Richards.

Mike joins from the Telegraph Media Group (TMG) where he held the role of General Manager - Digital with overall P&L responsibility for Digital Operations and Marketing. While with TMG, Mike authored and executed its digital monetisation and publishing strategy, the implementation of which helped significantly boost the global audience of Telegraph.co.uk from 9 to 22 million unique users, making it one of the most visited UK newspaper sites worldwide. 

Prior to TMG, Mike held high level sales, interactive marketing and commercial development roles at AOL Europe and America Online.

Kent Ertugrul, CEO of Phorm, commented: "Sarah and Mike have in depth experience of the Internet industry that is highly relevant to Phorm. Sarah has a distinguished track record of analysis and communication on media and internet stocks within the financial sector. Meanwhile Mike has the necessary relevant expertise in delivering successful digital media strategies. Their appointments will significantly strengthen our capabilities, both in terms of driving our business strategy and fully developing the commercial opportunities that flow from our innovative technology."

End

For Phorm Enquiries:

David Sawday - Communications Director 

Maria Greenwood - Press Officer 

Tel: 0207 297 2537

About Phorm: 

Phorm is an innovative advertising technology company specialising in precision targeted advertising which preserves users' personal privacy and security. Phorm's partners include leading Internet Service Providers (ISPs), Publishers, Ad Networks and Advertisers.

 

Phorm is a Delaware, US incorporated company, with offices in New York and London. 

The Company was admitted to the AIM market of the London Stock Exchange in 2004 

and has over 100 employees.

 

For more information, please visit: www.phorm.com http://www.phorm.com

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRADGGMFLMNGLZG
Date   Source Headline
22nd Feb 20088:25 amRNSStockholder Meeting
14th Feb 20087:01 amRNSISP agreements
1st Feb 20088:55 amRNSExercise of Options
28th Jan 20087:01 amRNSTransfer of Shares
15th Jan 20087:00 amRNSManagement Appointment
11th Jan 20085:01 pmRNSExercise of Options
20th Dec 20075:47 pmRNSDirector/PDMR Shareholding
17th Dec 20071:56 pmRNSExercise of Options
30th Nov 20075:32 pmRNSHolding(s) in Company
7th Nov 20072:06 pmRNSExercise of Options
1st Oct 20077:02 amRNSDirectorate Change
28th Sep 20078:02 amRNSInterim Results
12th Sep 20079:33 amRNSHolding(s) in Company
20th Aug 20077:00 amRNSAIM Rule 26
27th Jul 20073:27 pmRNSDirector/PDMR Shareholding
17th Jul 200710:03 amRNSDirector Change - Replacement
17th Jul 20079:12 amRNSDirectorate Change
13th Jul 20071:26 pmRNSExercise of options
18th Jun 20074:50 pmRNSNotification of Interest
18th Jun 20077:01 amRNSAdditional Listing
15th Jun 20077:58 amRNSStmnt re Share Price Movement
6th Jun 20074:11 pmRNSHolding(s) in Company
21st May 20077:02 amRNSDirectorate Change
16th May 20074:17 pmRNSIssue of Equity
4th May 20077:00 amRNSRe-Organisation
3rd May 20077:01 amRNSRe-Organisation
2nd May 20072:01 pmRNSPress speculation
1st May 20078:20 amRNSSch 1 Update - Phorm, Inc.
27th Apr 20074:27 pmRNSSch 1 Update - Phorm, Inc.
26th Apr 200711:52 amRNSNotification of Holding
26th Apr 200711:24 amRNSResult of AGM
24th Apr 20077:02 amRNSAnnual Results
12th Apr 20073:45 pmRNSExercise of Options
2nd Apr 200711:02 amRNSSchedule 1 - Phorm, Inc
2nd Apr 20077:02 amRNSNotice of AGM
8th Mar 20077:04 amRNSDirectorate Change
27th Feb 20077:04 amRNSIssue of Equity
1st Feb 200712:40 pmRNSHolding(s) in Company
21st Dec 20063:33 pmPRNTotal Voting Rights
6th Dec 200612:21 pmPRNAdditional Listing
3rd Nov 20063:05 pmPRNStatement re Share Price Movement
18th Aug 200610:45 amPRNAdditional Listing
28th Jul 20067:00 amPRNAdditional Listing
25th Jul 200612:00 pmPRN121Media appoints David Dorman as Adviser
25th Jul 200610:45 amPRNShare Incentive Plan
21st Jul 20067:00 amPRNUpdate on Trading in and settlement of common shares
20th Jul 20067:00 amPRNDirector/PDMR Shareholding
19th Jul 20067:00 amPRNUpdate re: ISP Partnership Strategy
23rd Jun 20064:12 pmPRNFormal Notice
16th Jun 20067:00 amPRNAppointment of EVP Operations

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.